Evidence map›Paper›PMID 40109198›Full record

ArticleHaematologica2025

Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research Network.

Alexandra Smith, Timothy Bagguley, Eve Roman, Simon Crouch, Russell Patmore, Ruth De Tute, Andy Rawstron, Gordon Cook, Frances Seymour, Christopher Parrish

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandra SmithEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD.
Timothy BagguleyEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD.
Eve RomanEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD.
Simon CrouchEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, YO10 5DD.
Russell PatmoreQueen's Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham, HU16 5JQ.
Ruth De TuteHaematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, LS9 7LP.
Andy RawstronHaematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, LS9 7LP.
Gordon CookDepartment of Haematology, Leeds Cancer Centre, St James's University Hospital, LS9 7LP.
Frances SeymourDepartment of Haematology, Leeds Cancer Centre, St James's University Hospital, LS9 7LP.
Christopher ParrishDepartment of Haematology, Leeds Cancer Centre, St James's University Hospital, LS9 7LP.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40109198
PMCPMC12399932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.